证券代码：839371 证券简称：欧福蛋业 公告编号：2024-038 4.发出董事会会议通知的时间和方式：2024 年 5 月 13 日以书面及通讯方式 发出 苏州欧福蛋业股份有限公司 第三届董事会第十八次会议决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 （一）会议召开情况 1.会议召开时间：2024 年 5 月 24 日 2.会议召开地点：公司现场会议室 3.会议召开方式：现场及通讯方式 5.会议主持人：董事长 Henrik Pedersen 6.会议列席人员：全体监事和高管 7.召开情况合法、合规、合章程性说明： 本次会议的召集、召开、议案审议程序符合《公司法》及相关法律、法规和 《公司章程》、《董事会议事规则》的规定。 （二）会议出席情况 会议应出席董事 8 人，出席和授权出席董事 8 人。 二、议案审议情况 （一）审议通过《关于变更募集资金用途及募投项目延期的议案》 1.议案内容： 具 体 内 容 详 见 公 司 于 同 日 在 北 京 证 券 交 易 所 ...

证券代码：839371 证券简称：欧福蛋业 公告编号：2024-039 苏州欧福蛋业股份有限公司 第三届监事会第十四次会议决议公告 本公司及监事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 （一）会议召开情况 6.召开情况合法、合规、合章程性说明： 本次会议的召集、召开、议案审议程序符合《公司法》、《公司章程》的相关 规定。 本议案尚需提交股东大会审议。 会议应出席监事 3 人，出席和授权出席监事 3 人。 二、议案审议情况 （一）审议通过《关于变更募集资金用途及募投项目延期的议案》 1.议案内容： 具 体 内 容 详 见 公 司 于 同 日 在 北 京 证 券 交 易 所 官 方 信 息 披 露 平 台 （www.bse.cn）披露的公司《变更募集资金用途及募投项目延期的公告》（公告 1.会议召开时间：2024 年 5 月 24 日 2.会议召开地点：公司现场会议室 3.会议召开方式：现场及通讯方式 4.发出监事会会议通知的时间和方式：2024 年 5 月 13 日以书面及通讯方式发出 ...

证券代码：839371 证券简称：欧福蛋业 公告编号：2024-037 苏州欧福蛋业股份有限公司 2023 年年度权益分派实施公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 苏州欧福蛋业股份有限公司 2023 年年度权益分派方案已获 2024 年 5 月 16 日召开的股东大会审议通过，本次实施分配方案距离股东大会审议通过的时间未 超过两个月。 现将权益分派事宜公告如下： 本次权益分派基准日合并报表归属于母公司的未分配利润为 169,546,096.89 元，母公司未分配利润为 134,365,543.63 元。本次权益分派共计派发现金红利 20,544,553.60 元。 一、权益分派方案 1、本公司 2023 年年度权益分派方案为： 以公司现有总股本 205,445,536 股为基数，向全体股东每 10 股派 1.000000 元人民币现金。 2、扣税说明 （1）个人股东、投资基金适用股息红利差别化个人所得税政策, 个人股东、 投资基金持股 1 个月（含 1 个月）以内，每 10 股补缴税款 ...

江苏新天伦（吴江）律师事务所 江苏新天伦 (吴江) 律师事务所 法律意见书 法律意见书 新天倫律師事務所 NEW TALENT LAW FIRM 苏州・太仓・吴江・北京・常熟 二零二四年五月 江苏新天伦(吴江)律师事务所 关于苏州欧福蛋业股份有限公司 2023 年年度股东大会的 法意见书 江苏新天伦(吴江)律师事务所 关于苏州欧福蛋业股份有限公司 2023 年年度股东大会的 法律意见书 致:苏州欧福蛋业股份有限公司 引言 江苏新天伦(吴江)律师事务所(以下简称"本所")接受苏州欧福蛋业股 份有限公司(以下简称"欧福蛋业"或"公司")委托,指派平佳翱律师、赵莹 莹律师(以下简称"本所律师")出席欧福蛋业 2023年年度股东大会(以下简 称"本次股东大会"),对本次股东大会的相关事宜进行见证,并出具法律意见 书。 本法律意见书根据《中华人民共和国公司法》(以下简称"《公司法》")、《中 华人民共和国证券法》(以下简称"《证券法》")等有关法律法规和规范性文件以 及《苏州欧福蛋业股份有限公司章程》(以下简称"《公司章程》")、《苏州欧福蛋 业股份有限公司股东大会议事规则》(以下简称"《股东大会议事规则》")的规定 ...

证券代码：839371 证券简称：欧福蛋业 公告编号：2024-035 苏州欧福蛋业股份有限公司 2023 年年度股东大会决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 （一）会议召开情况 1.会议召开时间：2024 年 5 月 16 日 2.会议召开地点：公司现场会议室 3.会议召开方式：现场投票、网络投票和其他投票方式相结合方式召开 4.会议召集人：董事会 5.会议主持人：Henrik Pedersen 6.召开情况合法、合规、合章程性说明： 本次股东大会的召开符合有关法律、行政法规、部门规章、规范性文件和《公 司章程》的规定。会议的召开经第三届董事会第十七次会议决议通过，履行了必 要的审批程序。 （二）会议出席情况 出席和授权出席本次股东大会的股东共 11 人，持有表决权的股份总数 149,140,093 股，占公司有表决权股份总数的 72.5935%。 其中通过网络投票参与本次股东大会的股东共 2 人，持有表决权的股份总数 50,608 股，占公司有表决权股份总 ...

证券代码：839371 证券简称：欧福蛋业 公告编号：2024-034 苏州欧福蛋业股份有限公司股票解除限售公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带法律责任。 一、本次股票解除限售数量总额为 1,212,361 股，占公司总股本 0.5901%，可交 易时间为 2024 年 5 月 20 日。 二、本次股票解除限售的明细情况及原因 单位：股 | 序号 | 股东姓 名或名 | 是否为 控股股 东、实 | 董事、 监事、 高级管 | 本次解 | 本次解 除限售 | 本次解 除限售 股数占 | 尚未解除 | | --- | --- | --- | --- | --- | --- | --- | --- | | | | 际控制 | | 限售原 | | | 限售的股 | | | 称 | 人或其 | 理人员 | 因 | 登记股 | 公司总 | 票数量 | | | | 一致行 | 任职情 | | 票数量 | 股本比 | | | | | | 况 | | | 例 | | | | | 动人 | | | | | | | 1 ...

证券代码：839371 证券简称：欧福蛋业 公告编号：2024-033 苏州欧福蛋业股份有限公司 投资者关系活动记录表 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、 投资者关系活动类别 □特定对象调研 √业绩说明会 □媒体采访 □现场参观 □新闻发布会 □分析师会议 □路演活动 □其他 二、 投资者关系活动情况 ...

证券代码：839371 证券简称：欧福蛋业 公告编号：2024-032 苏州欧福蛋业股份有限公司 2023 年年度报告业绩说明会预告公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、 说明会类型 苏州欧福蛋业股份有限公司（以下简称"公司"）于 2024 年 4 月 25 日在北 京证券交易所信息披露平台（www.bse.cn）披露了《2023 年年度报告》（公告编 号：2024-015）及《2023 年年度报告摘要》（公告编号：2024-016），为方便广 大投资者更深入了解公司 2023 年年度经营业绩的具体情况，加强与投资者的互 动交流，公司拟召开 2023 年年度报告业绩说明会。 四、 投资者参加方式 本次说明会采用网络方式召开。投资者可登陆上海证券报·中国证券网路演 中心（https://roadshow.cnstock.com/）参与本次年报业绩说明会。 为充分尊重投资者，提升交流的针对性，现就本次业绩说明会提前向投资者 公开征集问题，广泛听取投资者的意见和建议。投资者可于 2024 ...

Financial Performance - Net profit attributable to shareholders for Q1 2024 was CNY 19,301,064.44, representing a significant increase of 56.68% year-over-year[11]. - Operating revenue for Q1 2024 was CNY 233,233,842.40, a decrease of 0.34% compared to the same period last year[11]. - The company reported a 62.55% increase in operating profit, amounting to CNY 25,135,948.18, driven by improved gross margins[13]. - Total operating revenue for Q1 2024 was CNY 233,233,842.40, a slight decrease from CNY 234,034,475.01 in Q1 2023[37]. - Net profit for Q1 2024 increased to CNY 19,301,064.44, compared to CNY 12,318,895.10 in Q1 2023, reflecting a growth of approximately 56.7%[38]. - Earnings per share for Q1 2024 was CNY 0.09, up from CNY 0.07 in Q1 2023, indicating improved profitability on a per-share basis[38]. - Operating profit for Q1 2024 was ¥14,388,351.01, compared to ¥7,769,636.19 in Q1 2023, indicating a significant increase of approximately 84.5%[40]. - Net profit for Q1 2024 was ¥11,371,858.05, up from ¥6,544,016.42 in Q1 2023, reflecting an increase of about 73.5%[40]. - Total comprehensive income for Q1 2024 was ¥11,371,858.05, compared to ¥6,544,016.42 in Q1 2023, marking an increase of approximately 73.5%[41]. Cash Flow - The net cash flow from operating activities surged to CNY 27,752,034.71, marking a remarkable increase of 299.93% year-over-year[11]. - Cash flow from operating activities in Q1 2024 was ¥27,752,034.71, a substantial increase from ¥6,939,253.11 in Q1 2023[42]. - Cash inflow from operating activities in Q1 2024 was ¥267,239,193.91, compared to ¥249,396,639.10 in Q1 2023, representing an increase of about 7.1%[42]. - The net cash flow from financing activities in Q1 2024 was ¥0.00, compared to ¥117,678,125.00 in Q1 2023, reflecting a change in financing strategy[43]. - The net cash flow from operating activities was $12,895,232.46, an increase from $6,417,985.26[45]. - The total cash inflow from investing activities amounted to $23,260,952.84, compared to $375.90 in the previous period[45]. - The net cash outflow from investing activities was $15,764,097.23, up from $681,187.46[45]. - The cash and cash equivalents at the end of the period were $133,702,096.59, down from $166,357,686.80[45]. - The net increase in cash and cash equivalents was a decrease of $2,879,245.06, compared to an increase of $123,859,021.59 previously[45]. Assets and Liabilities - Total assets as of March 31, 2024, reached CNY 655,393,109.34, a slight increase of 0.30% compared to the end of 2023[11]. - The company's total liabilities to assets ratio decreased to 16.83% for the consolidated financials, down from 19.58% at the end of 2023[11]. - Total liabilities decreased to CNY 146,523,483.10 from CNY 156,848,478.64, showing a reduction in financial obligations[36]. - Current liabilities totaled ¥105,682,202.82, down from ¥123,527,702.85, reflecting a decrease of about 14.5%[32]. - Total liabilities decreased to ¥110,283,168.28 from ¥127,939,468.25, a reduction of approximately 13.9%[33]. - Non-current assets increased to ¥237,748,259.55 from ¥228,656,206.75, showing a growth of approximately 4.8%[32]. - The company's retained earnings rose to ¥188,847,161.33 from ¥169,546,096.89, an increase of about 11.4%[33]. - The total equity attributable to shareholders increased to ¥545,109,941.06 from ¥525,490,976.38, reflecting a growth of approximately 3.7%[33]. Shareholder Information - The total number of shares outstanding is 205,445,536, with 152,337,903 shares (74.15%) subject to restrictions[18]. - The largest shareholder, CHINA EGG PRODUCTS ApS, holds 135,188,506 shares, representing 65.80% of total shares[19]. - Liu Wen, a board member and general manager, owns 10,758,692 shares, accounting for 5.2368% of total shares[20]. - The company has 3,493 common shareholders[18]. - A commitment was made by China Egg Products ApS to extend the lock-up period for its pre-IPO restricted shares by 12 months until January 17, 2025[26]. - There are no pledges or judicial freezes on shares held by shareholders with more than 5% ownership[22]. Litigation and Claims - The company reported a total of 3,149,553.00 yuan in litigation claims, which is 0.58% of the net assets at the end of the reporting period[25]. - The company has no major litigation or arbitration matters during the reporting period[25]. Expenses and Investments - Sales expenses rose by 38.58% to CNY 6,619,301.70, reflecting increased marketing and promotional efforts[13]. - The company reported a significant reduction in financial expenses, with a net financial cost of CNY -435,165.54 compared to CNY 90,569.59 in the previous year[37]. - The company is focusing on research and development, with R&D expenses amounting to CNY 3,963,799.42 in Q1 2024, down from CNY 4,275,291.56 in Q1 2023[37]. - Research and development expenses for Q1 2024 were ¥3,963,443.65, down from ¥4,274,935.79 in Q1 2023, indicating a reduction of about 7.3%[40]. - Total cash outflow from investing activities in Q1 2024 was ¥41,527,262.52, significantly higher than ¥2,149,082.84 in Q1 2023, indicating increased investment activity[43].

Financial Performance - In 2023, Ovodan achieved a revenue of CNY 972,200,970.94, representing an increase of 8.94% compared to CNY 892,433,820.83 in 2022[25]. - The gross profit margin improved to 14.19% in 2023, up from 10.65% in 2022[25]. - Net profit attributable to shareholders reached CNY 43,161,415.83, a 20.54% increase from CNY 35,805,928.60 in the previous year[25]. - Operating revenue for 2023 was approximately ¥972.20 million, with an 8.94% increase compared to the previous year[28]. - The company's net cash flow from operating activities decreased by 5.62% to approximately ¥56.07 million[27]. - The weighted average return on equity based on net profit attributable to shareholders was 8.55% in 2023, down from 9.68% in 2022[25]. - Basic earnings per share decreased by 4.35% to CNY 0.22 in 2023, compared to CNY 0.23 in 2022[25]. - Total assets increased by 27.29% year-over-year, reaching approximately ¥653.43 billion in 2023[27]. - Operating profit increased by 60.25% to ¥54,074,276.65, driven by revenue growth and improved gross margin[51]. - The company achieved operating revenue of ¥972,200,970.94, an increase of 8.94% year-on-year, and net profit of ¥43,161,415.83, up 20.54% year-on-year[40]. Product Development and Innovation - The company launched a new egg protein drink, which won the "Product Innovation Award" at the FNS2023 International Seminar on Food Nutrition and Safety[7]. - The company was awarded the "Special Contribution Award for Innovation Leadership" at the 12th Annual Seven Star Awards, highlighting its commitment to innovation and high-quality development[6]. - R&D expenses amounted to ¥18,170,109.73, representing 1.87% of operating revenue, supporting continuous product innovation and the launch of a new protein drink[40]. - The company expanded its product line into prepared foods, with revenue from prepared products increasing by 8.31% year-on-year, capitalizing on a market projected to grow at a compound annual growth rate of 29.25% from 2022 to 2025[43]. - The company launched a new protein drink (egg white beverage) in November 2023, marking a first in the domestic market and enhancing its product matrix[40]. - Ongoing R&D projects include the development of high-value egg products and welfare breeding techniques, which are anticipated to enhance product quality and market competitiveness[78][80]. Market Expansion and Strategy - Ovodan signed an investment cooperation agreement for a new production base in Yanjing District, aiming to enhance regional collaboration and expand its presence in the southwest region of China[7]. - The company actively expanded online sales channels, successfully launching products on major platforms like Tmall, JD, and Douyin, while also collaborating with retail giants like Costco[43]. - The company aims to develop a high-value product line including pre-made egg products and high-tech lysozyme, enhancing market competitiveness[95]. - The company plans to expand retail market presence by launching ready-to-eat egg products and convenience foods, targeting modern consumers seeking quick and healthy meal options[96]. - The company’s development strategy focuses on geographical expansion to establish a broader customer base and gradually moving from basic egg product processing to deep processing to enter higher value-added segments of the industry[94]. Financial Management and Governance - The company has established a comprehensive internal control system to mitigate risks associated with the actual controller's influence on operational decisions[98]. - The company has implemented measures to protect shareholder rights, ensuring that all shareholders can exercise their rights effectively[157]. - The company has established independent financial management systems, including separate bank accounts for its subsidiaries, ensuring financial autonomy[178]. - The company has a structured investor relations management system, with the board secretary responsible for coordinating communication with stakeholders[184]. - The company has implemented a diversified communication approach with investors, including hotlines and email, to enhance interaction and ensure timely information disclosure[185]. Shareholder and Capital Structure - The total number of ordinary shares increased from 153,695,536 to 205,445,536 due to a public offering of 51,750,000 shares[117]. - The largest shareholder, CHINA EGG PRODUCT S ApS, holds 135,188,506 shares, representing 65.80% of the total shares[118]. - The company successfully issued 51,750,000 shares at a price of 2.50, raising a total of 129,375,000.00 yuan for various projects[127]. - The net amount raised after deducting issuance costs was 112,822,477.86 yuan[131]. - The company has no significant related party transactions that are applicable for the reporting period[108]. Risk Management - The company’s risk control measures include proactive prevention and ongoing monitoring of market, policy, operational, and legal risks[180]. - The company will conduct futures and derivatives hedging business as part of its risk management strategy[164]. - The company is expected to apply for bank loans and comprehensive credit lines in 2023[164]. Employee and Management Structure - The total number of employees at the end of the reporting period was 353, a decrease of 2 from the beginning of the period[145]. - The company has implemented a comprehensive labor contract system for all employees, ensuring compliance with social insurance regulations[146]. - The number of technical staff increased from 85 to 89, indicating a focus on enhancing technical capabilities[144]. - The company has tailored training programs for employees at different levels to improve professional skills and management capabilities[146]. Audit and Compliance - The audit report issued by Tianzhi International Accounting Firm confirmed that the financial statements fairly reflect the company's financial position and operating results for the year ended December 31, 2023[188]. - The audit opinion was unqualified, indicating no significant issues were found during the audit process[187]. - The company has established a management system for significant errors in annual report disclosures, with no major accounting errors or omissions reported during the period[182]. - The company has made no significant illegal or regulatory violations in its governance practices[166].